To account for this, a weighted cohort approach is suggested by Antoniou et al.,32 in which women with breast cancer and unaffected women are differentially weighted such that the breast cancer incidence rates in the study cohort are consistent with age- and birth cohort–specific breast cancer risk estimates for BRCA1 and BRCA2 mutation carriers. The gene discussed is BRCA2; the disease is breast cancer.